Skip to content
The Nexus
DossierENTITY

antibody therapies

Coverage of antibody therapies in the Nexus archive.

Earliest in view: Jun 9 · 13:38 UTCMost recent: Jun 9 · 13:38 UTC
Co-mentioned in this coverage
GSKorganization1Nuvalentorganization1Merckorganization1cancertopic1Tom Chiversperson1
Recent coverage
  • HEALTHJun 9 · 13:38 UTCSEMAFOR
    GSK buys cancer drugmaker Nuvalent for $10B

    GSK acquired cancer drugmaker Nuvalent for $10.6 billion, reflecting the rising significance of cancer in the pharmaceutical market. The move aims to leverage Nuvalent’s antibody therapies to compete with companies like Merck, as cancer becomes more prevalent and treatable due to aging populations and advancements in detection and treatment.